Phase 2 Malignant Mesothelioma Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma
Peritoneal Malignant Mesothelioma
National Cancer Institute (NCI)66 enrolled40 locationsNCT05001880
Recruiting
Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
Malignant MesotheliomaCD30-Positive Neoplastic Cells Present
M.D. Anderson Cancer Center55 enrolled1 locationNCT03007030
Recruiting
Phase 2
A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma
Malignant MesotheliomaMesotheliomaMesothelioma, Malignant+2 more
Memorial Sloan Kettering Cancer Center64 enrolled13 locationsNCT06057935
Terminated
Phase 2
A two stage, open-label, phase II trial assessing the efficacy of a single oral agent AZD4547 in malignant mesothelioma.
Malignant Mesothelioma
Institute of Respiratory Health55 enrolled1 locationACTRN12615001291572